TLR4 and COVID-19: There is emerging evidence that direct activation of TLR4 in alveolar macrophages (AMΦ) by the SARS-CoV-2 spike protein may play a pivotal role in strong pro-inflammatory responses and associated acute lung injury (ALI) observed in severe COVID-19 [16,17].